Serum regulates the expression of complement receptor 2 on human B cell lines

Immunopharmacology and Immunotoxicology

Volumn 22, Issue 2, 2000, Pages 205-219

  Tolnay, M ^a   Tsokos, G C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAJI CELL; SERUM;

BOVINAE;

EID: 0033841668     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923970009016416     Document Type: Article

References (38)

1. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
2. Complement and the immune response
3. Complement receptor 2 in the regulation of the immune response
4. Co-receptors of B lymphocytes
5. The CD19/CD21 signal transduction complex of B lymphocytes
6. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes
7. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus
8. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs
9. The generation of memory B cells. I. The role of C3 in the generation of B memory cells
10. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
11. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
12. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody
13. Human marginal zone B cells are not an activated B cell subset: Strong expression of CD21 as a putative mediator for rapid B cell activation
14. Mouse complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21) expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/1pr mice
15. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins
16. Identification of 5'-regions affecting the expression of the human CR2 gene
17. Expression of the murine CD21 gene is regulated by promoter and intronic sequences
18. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene
19. Transcriptional regulation of the complement receptor 2 gene: Role of a heterogeneous nucler ribonucleoprotein
20. Ternary complex factors: Growth factor regulated transcriptional activators
21. Use of flow cytometry for DNA analysis
22. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes
23. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
24. Northern hybridization
25. Intersection of the complement and immune systems: A signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19
26. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules
27. The CR2 receptor (CD21) shows increased expression in the more differentiated cells of an antigen-specific B cell line
28. Cell cycle control of a Burkitt lymphoma cell line: Responsiveness to growth signals engaging the C3D/EBV receptor
29. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: A signal for growth arrest?
30. Suppression of growth factor-induced CYCL1 cyclin gene expression by antiproliferative agents
31. Inhibition of coloni-stimulating factor-stimulated macrophage proliferation by tumor necrosis factor-alpha, IFN-gamma, and lipopolysaccharide is not due to a general loss of responsiveness to growth factor
32. Differential responsiveness of human bronchial epithelial cells, lung carcinoma cells, and bronchial fibroblasts to interferon-gamma in vitro
33. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: Their role in sensitivity to human serum-mediated lysis
34. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells
35. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells
36. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line
37. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences
38. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors